40.0 D

BPC-157

Also known as: Body Protection Compound 157, PL 14736

Emerging Research Category 2 Restricted
Research Evidence 30.0/100
Safety Profile 50.0/100

2 Clinical Trials

PHASE2: 1 PHASE1: 1

7 Research Papers

Showing 5 of 7 papers by citation count.

FDA Data

Not FDA-Approved

BPC-157 has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.

This peptide is classified as FDA Category 2 — it is prohibited from use in compounding pharmacies effective 2024. Obtaining it requires unregulated sources.

Frequently Asked Questions

Is BPC-157 FDA approved?
No, BPC-157 is not FDA approved. It is classified as FDA Category 2 and is banned from compounding pharmacies.
How many clinical trials has BPC-157 been studied in?
BPC-157 has been studied in 2 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for BPC-157?
BPC-157 has a CheckPeptides trust score of 40.0/100 (grade: D). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026

Quick Facts

Classification
Pentadecapeptide
Molecular Weight
1419.5 Da
Regulatory Status
N/A

Score Breakdown

Research Evidence 30.0/100
Safety Profile 50.0/100

Evidence Summary

Clinical Trials
2
Research Papers
7
Trust Score
40.0/100
Grade
D

Compare Peptides

See how BPC-157 stacks up against similar peptides.

View Comparisons
← Browse all peptides